학술논문
Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial
Document Type
Article
Author
Source
In Clinical Microbiology and Infection February 2023 29(2):215-220
Subject
Language
ISSN
1198-743X